Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2052 ARTÍCULOS , VIENDO DEL 1786 AL 1800

Oxidative stress, the immune response, synaptic plasticity, and cognition in transgenic models of Alzheimer disease

Bello-Medina PC, González-Franco DA, Vargas-Rodríguez I, Díaz-Cintra S.

Neurologia (Engl Ed). 2022 Oct;37(8):682-690. doi: 10.1016/j.nrl.2019.06.002. Epub 2019 Nov 25.

Seeing though the clutter: A case report of Posterior Cortical Atrophy and patient-centered care

Bailey KC, Sandlin EK, Brickell EE, Gardner A.

Appl Neuropsychol Adult. 2022 Jan-Feb;29(1):139-145. doi: 10.1080/23279095.2019.1704286. Epub 2019 Dec 19.

Diagnostic performance of brief cognitive tests in cognitive impairment screening

Carnero-Pardo C, Rego-García I, Mené Llorente M, Alonso Ródenas M, Vílchez Carrillo R.

Neurologia (Engl Ed). 2022 Jul-Aug;37(6):441-449. doi: 10.1016/j.nrl.2019.05.007. Epub 2019 Aug 8.

A Systematic Review and Meta-Analysis of Dyadic Psychological Interventions for BPSD, Quality of Life and/or Caregiver Burden in Dementia or MCI

Poon E.

Clin Gerontol. 2022 Jul-Sep;45(4):777-797. doi: 10.1080/07317115.2019.1694117. Epub 2019 Nov 22.

The Alteration of Neurogenesis and Pathological Markers in Alzheimer's Disease After Deep Brain Stimulation

Nassehi B, Kocabicak E, Temel Y, Hescham S.

Turk Neurosurg. 2022;32(4):535-548. doi: 10.5137/1019-5149.JTN.35598-21.2.

Progressive supranuclear palsy with predominant frontal presentation exhibiting progressive nonfluent aphasia due to crossed aphasia

Ono Y, Higashida K, Yoshikura N, Hayashi Y, Kimura A, Iwasaki Y, Yoshida M, Shimohata T.

Neuropathology. 2022 Jun;42(3):232-238. doi: 10.1111/neup.12805. Epub 2022 Apr 17.

Multiscale imaging informs translational mouse modeling of neurological disease

Wang Y, LeDue JM, Murphy TH.

Neuron. 2022 Nov 16;110(22):3688-3710. doi: 10.1016/j.neuron.2022.09.006. Epub 2022 Oct 4.

Does essential tremor increase risk of cognitive impairment and dementia? Yes

Cosentino S, Shih LC.

Int Rev Neurobiol. 2022;163:195-231. doi: 10.1016/bs.irn.2022.02.011. Epub 2022 Apr 9.

A Review on Chitosan in Drug Delivery for Treatment of Neurological and Psychiatric Disorders

Shayganfard M.

Curr Pharm Biotechnol. 2022;23(4):538-551. doi: 10.2174/1389201022666210622111028.

Implication of Covid-19 on Neurological Complications with Specific Emphasis on Alzheimer's and Parkinson's Disease

Sood A, Goyal R, Singh H, Behl T, Arora S, Saini B, Kaur R.

CNS Neurol Disord Drug Targets. 2022;21(3):235-245. doi: 10.2174/1871527320666210820092817.

Squalamine and trodusquemine: two natural products for neurodegenerative diseases, from physical chemistry to the clinic

Limbocker R, Errico S, Barbut D, Knowles TPJ, Vendruscolo M, Chiti F, Zasloff M.

Nat Prod Rep. 2022 Apr 20;39(4):742-753. doi: 10.1039/d1np00042j.

A Brewed Awakening: Neuropsychiatric Effects of Caffeine in Older Adults

Kim E, Robinson NM, Newman BM.

Clin Geriatr Med. 2022 Feb;38(1):133-144. doi: 10.1016/j.cger.2021.07.009.

Current Research on Pro-drug Therapies for Parkinson's and Alzheimer's Disease

Huo C, Wu L, Jiang Z, Yang J, Wang Z, Li Y, Qian S.

Med Chem. 2022;18(6):655-666. doi: 10.2174/1573406418666211130150821.

The influence of cerebrovascular disease in dementia with Lewy bodies and Parkinson's disease dementia

Hijazi Z, Yassi N, O'Brien JT, Watson R.

Eur J Neurol. 2022 Apr;29(4):1254-1265. doi: 10.1111/ene.15211. Epub 2022 Jan 20.

Challenges of repurposing tetracyclines for the treatment of Alzheimer's and Parkinson's disease

Markulin I, Matasin M, Turk VE, Salković-Petrisic M.

J Neural Transm (Vienna). 2022 Jun;129(5-6):773-804. doi: 10.1007/s00702-021-02457-2. Epub 2022 Jan 4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias